Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jingfang Mixture for Chronic Urticaria (Phase IIb, randomized, double-blind, placebo-controlled)
CTR20253027Phase 2Active
- Sponsor
- Lunan Houpu Pharmaceutical Co., Ltd.
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of jingfang mixture in chronic urticaria (CU), sponsored by Lunan Houpu Pharmaceutical Co., Ltd.. Started Nov 2025; status: active.
02
Drugs
jingfang mixture
03
Conditions
chronic urticaria (CU)
Beyond the preview
Go deeper on CTR20253027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253027.